• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

UltraSOL CurcuMIN line & CurcuWIN granted patent for sports performance benefits

Bioengineer by Bioengineer
September 12, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Morristown, N.J., September 12, 2017 – OmniActive Health Technologies has been granted a US patent (Patent No: US 9724311) for the highly bioavailable, clinically-studied UltraSOL line of curcumin ingredients, including CurcuWIN, for their sports nutrition and performance benefits. The patent covers these proprietary ingredients' compositions for improving muscle performance, endurance capacity and resistance to fatigue when administered in effective amounts in humans undergoing exercise.

This patent opens new opportunities for supplementation to meet current lifestyle needs. While turmeric has a long history as a traditional herb, the last few decades have seen an upsurge in research of pure forms of curcumin (the principal curcuminoid of turmeric) primarily directed towards disease conditions such as cancer and arthritis. However, because done in diseased populations, this research could not be directly translated to the general public nor used to support claims. This patent and its supporting science addresses the evolving needs of a modern, active lifestyle further expanding on curcumin's potential.

Over the last few years, turmeric has become a supplement sensation, climbing the ranks as a top ingredient and now, more than ever, the importance of clinically-demonstrated benefits and enhanced absorption has come center stage. The UltraSOL line of curcumin ingredients was developed to address the issue of absorption and CurcuWIN has been shown to be 46 times more bioavailable than standard curcumin (Jaeger, 2014). But modern lifestyles have generated the need for ingredients that go beyond just high bioavailability to include unique benefits and attributes.

"Our unique platform and composition has not only solved the poor absorption issue of curcumin but, under this patent, is now the only curcumin tested on healthy subjects with demonstrated sports and nutrition benefits to support healthy living," said Abhijit Bhattacharya, President of OmniActive Health Technologies Ltd. "The UltraSOL line of curcumin addresses the needs of a much broader population including those who are living active lifestyles."

###

Media Contact

Christopher Andraka
[email protected]
973-270-7266
@OmniActive_Life

http://omniactives.com/

Share12Tweet7Share2ShareShareShare1

Related Posts

HKU25 Clade MERS Coronaviruses Utilize ACE2 Receptor

HKU25 Clade MERS Coronaviruses Utilize ACE2 Receptor

October 30, 2025
blank

Halotolerant Staphylococcus Boosts Rice Salinity Tolerance

October 30, 2025

HIV and Antiretrovirals Impact Diverse Gut Microbiomes

October 30, 2025

ZmDapF1 Variation Boosts Maize Drought Resilience

October 30, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1291 shares
    Share 516 Tweet 322
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    201 shares
    Share 80 Tweet 50
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    136 shares
    Share 54 Tweet 34
/div>

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Physiotherapy Approaches for Post- and Long-COVID Care

Study Reveals Common Misconceptions Among Americans About Alcohol and Cancer Risk

Streamlined CRISPR Evaluation Boosts Rare Variant Discovery

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.